Can pharmacotherapy effectively reduce Alzheimer's related agitation?

Treatment of neuropsychiatric symptoms (NPS) represents a major clinical challenge in Alzheimer’s disease (AD). Among NPS, agitation and aggression increase patient morbidity and mortality and care...